SlideShare a Scribd company logo
Postulated Mechanisms of Insulin ResistancePostulated Mechanisms of Insulin Resistance
PTP-1BPTP-1B Mass & ActivityMass & Activity
Impaired Phosphorylation ofImpaired Phosphorylation of
Insulin Receptor, IRS-1Insulin Receptor, IRS-1
PI-3 Kinase ActivityPI-3 Kinase Activity
Attenuated Insulin SignalingAttenuated Insulin Signaling
Reduced Phosphorylation of ApoB orReduced Phosphorylation of ApoB or
an apoB-chaperonean apoB-chaperone
Enhanced Stability and Accelerated Assembly of ApoBEnhanced Stability and Accelerated Assembly of ApoB
Overproduction of VLDLOverproduction of VLDL
ER-60MTP
Intestine
Contribution of the Intestinal LipoproteinsContribution of the Intestinal Lipoproteins
to Metabolic Dyslipidemia in Insulin Resistanceto Metabolic Dyslipidemia in Insulin Resistance
Liver
ApoB48
ApoB100
Intestinal Lipoprotein Metabolism
DietaryDietary
CholesterolCholesterol
DietaryDietary
FatFat
LuminalLuminal
TriglycerideTriglyceride
LipasesLipases
Bile AcidsBile Acids
Fatty AcidsFatty Acids
Mocellar CholesterolMocellar Cholesterol
Fatty AcidsFatty Acids
CholrdyrtolCholrdyrtol
ApoB48 + TG + CEApoB48 + TG + CE
TGTG
CMCM
ABCA1ABCA1
ABCG5ABCG5
ABCG8ABCG8
Fatty Acid TransportersFatty Acid Transporters
Intestinal Epithelial CellIntestinal Epithelial Cell
(Intake)(Intake)
(Uptake)(Uptake)
(Chylomicron(Chylomicron
Assembly)Assembly)
(Cholesterol(Cholesterol
Excretion)Excretion)
Intestinal Lipid Absorption
(Trigleride(Trigleride
Synthesis)Synthesis)
Hypothesis III:
Fasting and postprandial hyperlipidemia in insulin resistant states
may be attributable in part to intestinal oversecretion of apoB-48
containing lipoproteins
Experimental Approach:
• Dietary induction of an insulin resistant state in the hamster by
high fructose feeding
• Isolation of adult viable villi from Syrian hamster small intestine.
• -In Vivo Studies to assess production rate of intestinal (apoB48-
containing) lipoproteins
• -Ex Vivo Studies to assess intestinal apoB48 lipoprotein synthesis
and secretion, mechanisms of chylomicron assembly, role of de
novo lipogenesis in intestinal lipoprotein secretion in the fasting
and postprandial states

More Related Content

Viewers also liked

145 intravascular elastography
145 intravascular elastography145 intravascular elastography
145 intravascular elastography
SHAPE Society
 
156 intravascular elastography
156 intravascular elastography156 intravascular elastography
156 intravascular elastography
SHAPE Society
 
198 pulse sequences
198 pulse sequences198 pulse sequences
198 pulse sequences
SHAPE Society
 
213 oral apo ai mimetic peptide for reduction of atherosclerosis
213 oral apo ai mimetic peptide for reduction of atherosclerosis213 oral apo ai mimetic peptide for reduction of atherosclerosis
213 oral apo ai mimetic peptide for reduction of atherosclerosis
SHAPE Society
 
507 stenosis severity and risk benefit
507 stenosis severity and risk benefit507 stenosis severity and risk benefit
507 stenosis severity and risk benefit
SHAPE Society
 
210 atherosclerosis, is it an autoimmune disease
210 atherosclerosis, is it an autoimmune disease210 atherosclerosis, is it an autoimmune disease
210 atherosclerosis, is it an autoimmune disease
SHAPE Society
 
218 pharmacologic stabilization of vulnerable plaque
218 pharmacologic stabilization of vulnerable plaque218 pharmacologic stabilization of vulnerable plaque
218 pharmacologic stabilization of vulnerable plaque
SHAPE Society
 
250 patients with very abnormal test results
250 patients with very abnormal test results250 patients with very abnormal test results
250 patients with very abnormal test results
SHAPE Society
 
092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis
SHAPE Society
 
080 intravascular micro bolometer catheter
080 intravascular micro bolometer catheter080 intravascular micro bolometer catheter
080 intravascular micro bolometer catheter
SHAPE Society
 
172 nir spectroscopy
172 nir spectroscopy172 nir spectroscopy
172 nir spectroscopy
SHAPE Society
 
046 respiratory infection of apoe ko mice and plaque inflammation
046 respiratory infection of apoe ko mice and plaque inflammation046 respiratory infection of apoe ko mice and plaque inflammation
046 respiratory infection of apoe ko mice and plaque inflammation
SHAPE Society
 
181 cholesterol independent therapeutic effects of hdl
181 cholesterol independent therapeutic effects of hdl181 cholesterol independent therapeutic effects of hdl
181 cholesterol independent therapeutic effects of hdl
SHAPE Society
 
233 cd40
233 cd40233 cd40
233 cd40
SHAPE Society
 
3rd vulnerable plaque rumberger 3 16-02 4
3rd vulnerable plaque rumberger 3 16-02 43rd vulnerable plaque rumberger 3 16-02 4
3rd vulnerable plaque rumberger 3 16-02 4
SHAPE Society
 
104 new advances in thermography
104 new advances in thermography104 new advances in thermography
104 new advances in thermography
SHAPE Society
 
236 complement inhibitor
236 complement inhibitor236 complement inhibitor
236 complement inhibitor
SHAPE Society
 
054 vulnerable plaques and vulnerable patients
054 vulnerable plaques and vulnerable patients054 vulnerable plaques and vulnerable patients
054 vulnerable plaques and vulnerable patients
SHAPE Society
 
226 statins are overrated
226 statins are overrated226 statins are overrated
226 statins are overrated
SHAPE Society
 
228 crp, is it a risk factor not a risk marker
228 crp, is it a risk factor not a risk marker228 crp, is it a risk factor not a risk marker
228 crp, is it a risk factor not a risk marker
SHAPE Society
 

Viewers also liked (20)

145 intravascular elastography
145 intravascular elastography145 intravascular elastography
145 intravascular elastography
 
156 intravascular elastography
156 intravascular elastography156 intravascular elastography
156 intravascular elastography
 
198 pulse sequences
198 pulse sequences198 pulse sequences
198 pulse sequences
 
213 oral apo ai mimetic peptide for reduction of atherosclerosis
213 oral apo ai mimetic peptide for reduction of atherosclerosis213 oral apo ai mimetic peptide for reduction of atherosclerosis
213 oral apo ai mimetic peptide for reduction of atherosclerosis
 
507 stenosis severity and risk benefit
507 stenosis severity and risk benefit507 stenosis severity and risk benefit
507 stenosis severity and risk benefit
 
210 atherosclerosis, is it an autoimmune disease
210 atherosclerosis, is it an autoimmune disease210 atherosclerosis, is it an autoimmune disease
210 atherosclerosis, is it an autoimmune disease
 
218 pharmacologic stabilization of vulnerable plaque
218 pharmacologic stabilization of vulnerable plaque218 pharmacologic stabilization of vulnerable plaque
218 pharmacologic stabilization of vulnerable plaque
 
250 patients with very abnormal test results
250 patients with very abnormal test results250 patients with very abnormal test results
250 patients with very abnormal test results
 
092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis
 
080 intravascular micro bolometer catheter
080 intravascular micro bolometer catheter080 intravascular micro bolometer catheter
080 intravascular micro bolometer catheter
 
172 nir spectroscopy
172 nir spectroscopy172 nir spectroscopy
172 nir spectroscopy
 
046 respiratory infection of apoe ko mice and plaque inflammation
046 respiratory infection of apoe ko mice and plaque inflammation046 respiratory infection of apoe ko mice and plaque inflammation
046 respiratory infection of apoe ko mice and plaque inflammation
 
181 cholesterol independent therapeutic effects of hdl
181 cholesterol independent therapeutic effects of hdl181 cholesterol independent therapeutic effects of hdl
181 cholesterol independent therapeutic effects of hdl
 
233 cd40
233 cd40233 cd40
233 cd40
 
3rd vulnerable plaque rumberger 3 16-02 4
3rd vulnerable plaque rumberger 3 16-02 43rd vulnerable plaque rumberger 3 16-02 4
3rd vulnerable plaque rumberger 3 16-02 4
 
104 new advances in thermography
104 new advances in thermography104 new advances in thermography
104 new advances in thermography
 
236 complement inhibitor
236 complement inhibitor236 complement inhibitor
236 complement inhibitor
 
054 vulnerable plaques and vulnerable patients
054 vulnerable plaques and vulnerable patients054 vulnerable plaques and vulnerable patients
054 vulnerable plaques and vulnerable patients
 
226 statins are overrated
226 statins are overrated226 statins are overrated
226 statins are overrated
 
228 crp, is it a risk factor not a risk marker
228 crp, is it a risk factor not a risk marker228 crp, is it a risk factor not a risk marker
228 crp, is it a risk factor not a risk marker
 

Similar to 183 postulated mechanisms of insulin resistance

Adeli 21 24
Adeli 21 24Adeli 21 24
Slides 21 24
Slides 21 24Slides 21 24
170 insulin signaling & vldl overproduction
170 insulin signaling & vldl overproduction170 insulin signaling & vldl overproduction
170 insulin signaling & vldl overproduction
SHAPE Society
 
170 insulin signaling & vldl overproduction
170 insulin signaling & vldl overproduction170 insulin signaling & vldl overproduction
170 insulin signaling & vldl overproduction
Society for Heart Attack Prevention and Eradication
 
Slides2124
Slides2124Slides2124
Adipokines
AdipokinesAdipokines
Glycolysis .pptx
 Glycolysis .pptx Glycolysis .pptx
Glycolysis .pptx
HesocaHux
 
Insulin recent updates final
Insulin recent updates finalInsulin recent updates final
Insulin recent updates final
Meeta Burande
 
Adipokines
AdipokinesAdipokines
Adipokines
Tulasi Raman
 
Insulin resistance causes and consequences
Insulin resistance causes and  consequences Insulin resistance causes and  consequences
Insulin resistance causes and consequences
Dr. Kapil Dev Doddamani
 
INSULIN & ITS PREPARATIONS
INSULIN & ITS PREPARATIONSINSULIN & ITS PREPARATIONS
INSULIN & ITS PREPARATIONS
Kameshwaran Sugavanam
 
Citrulline
CitrullineCitrulline
Citrulline
Arun Babu
 
Newer drug targets for obesity
Newer drug targets for obesityNewer drug targets for obesity
Newer drug targets for obesity
Siddharth Naruka
 
glucagon disorder
glucagon disorder glucagon disorder
glucagon disorder
Amer
 
Slides18
Slides18Slides18
201 metabolic dyslipidemia
201 metabolic dyslipidemia201 metabolic dyslipidemia
201 metabolic dyslipidemia
SHAPE Society
 
201 metabolic dyslipidemia
201 metabolic dyslipidemia201 metabolic dyslipidemia
Adeli 1 8
Adeli 1 8Adeli 1 8
Slides 1 8
Slides 1 8Slides 1 8
haemoglobin_synthesis_and_degradation.pdf
haemoglobin_synthesis_and_degradation.pdfhaemoglobin_synthesis_and_degradation.pdf
haemoglobin_synthesis_and_degradation.pdf
TahreemFatima43565
 

Similar to 183 postulated mechanisms of insulin resistance (20)

Adeli 21 24
Adeli 21 24Adeli 21 24
Adeli 21 24
 
Slides 21 24
Slides 21 24Slides 21 24
Slides 21 24
 
170 insulin signaling & vldl overproduction
170 insulin signaling & vldl overproduction170 insulin signaling & vldl overproduction
170 insulin signaling & vldl overproduction
 
170 insulin signaling & vldl overproduction
170 insulin signaling & vldl overproduction170 insulin signaling & vldl overproduction
170 insulin signaling & vldl overproduction
 
Slides2124
Slides2124Slides2124
Slides2124
 
Adipokines
AdipokinesAdipokines
Adipokines
 
Glycolysis .pptx
 Glycolysis .pptx Glycolysis .pptx
Glycolysis .pptx
 
Insulin recent updates final
Insulin recent updates finalInsulin recent updates final
Insulin recent updates final
 
Adipokines
AdipokinesAdipokines
Adipokines
 
Insulin resistance causes and consequences
Insulin resistance causes and  consequences Insulin resistance causes and  consequences
Insulin resistance causes and consequences
 
INSULIN & ITS PREPARATIONS
INSULIN & ITS PREPARATIONSINSULIN & ITS PREPARATIONS
INSULIN & ITS PREPARATIONS
 
Citrulline
CitrullineCitrulline
Citrulline
 
Newer drug targets for obesity
Newer drug targets for obesityNewer drug targets for obesity
Newer drug targets for obesity
 
glucagon disorder
glucagon disorder glucagon disorder
glucagon disorder
 
Slides18
Slides18Slides18
Slides18
 
201 metabolic dyslipidemia
201 metabolic dyslipidemia201 metabolic dyslipidemia
201 metabolic dyslipidemia
 
201 metabolic dyslipidemia
201 metabolic dyslipidemia201 metabolic dyslipidemia
201 metabolic dyslipidemia
 
Adeli 1 8
Adeli 1 8Adeli 1 8
Adeli 1 8
 
Slides 1 8
Slides 1 8Slides 1 8
Slides 1 8
 
haemoglobin_synthesis_and_degradation.pdf
haemoglobin_synthesis_and_degradation.pdfhaemoglobin_synthesis_and_degradation.pdf
haemoglobin_synthesis_and_degradation.pdf
 

More from SHAPE Society

Barth imt
Barth imtBarth imt
Barth imt
SHAPE Society
 
Braunwald
BraunwaldBraunwald
Braunwald
SHAPE Society
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
SHAPE Society
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
SHAPE Society
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
SHAPE Society
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
SHAPE Society
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
SHAPE Society
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
SHAPE Society
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
SHAPE Society
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
SHAPE Society
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
SHAPE Society
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
SHAPE Society
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
SHAPE Society
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
SHAPE Society
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
SHAPE Society
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
SHAPE Society
 
A20 gene
A20 geneA20 gene
A20 gene
SHAPE Society
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
SHAPE Society
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
SHAPE Society
 
103100
103100103100

More from SHAPE Society (20)

Barth imt
Barth imtBarth imt
Barth imt
 
Braunwald
BraunwaldBraunwald
Braunwald
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
A20 gene
A20 geneA20 gene
A20 gene
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
 
103100
103100103100
103100
 

Recently uploaded

Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 

Recently uploaded (20)

Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 

183 postulated mechanisms of insulin resistance

  • 1. Postulated Mechanisms of Insulin ResistancePostulated Mechanisms of Insulin Resistance PTP-1BPTP-1B Mass & ActivityMass & Activity Impaired Phosphorylation ofImpaired Phosphorylation of Insulin Receptor, IRS-1Insulin Receptor, IRS-1 PI-3 Kinase ActivityPI-3 Kinase Activity Attenuated Insulin SignalingAttenuated Insulin Signaling Reduced Phosphorylation of ApoB orReduced Phosphorylation of ApoB or an apoB-chaperonean apoB-chaperone Enhanced Stability and Accelerated Assembly of ApoBEnhanced Stability and Accelerated Assembly of ApoB Overproduction of VLDLOverproduction of VLDL ER-60MTP
  • 2. Intestine Contribution of the Intestinal LipoproteinsContribution of the Intestinal Lipoproteins to Metabolic Dyslipidemia in Insulin Resistanceto Metabolic Dyslipidemia in Insulin Resistance Liver ApoB48 ApoB100 Intestinal Lipoprotein Metabolism
  • 3. DietaryDietary CholesterolCholesterol DietaryDietary FatFat LuminalLuminal TriglycerideTriglyceride LipasesLipases Bile AcidsBile Acids Fatty AcidsFatty Acids Mocellar CholesterolMocellar Cholesterol Fatty AcidsFatty Acids CholrdyrtolCholrdyrtol ApoB48 + TG + CEApoB48 + TG + CE TGTG CMCM ABCA1ABCA1 ABCG5ABCG5 ABCG8ABCG8 Fatty Acid TransportersFatty Acid Transporters Intestinal Epithelial CellIntestinal Epithelial Cell (Intake)(Intake) (Uptake)(Uptake) (Chylomicron(Chylomicron Assembly)Assembly) (Cholesterol(Cholesterol Excretion)Excretion) Intestinal Lipid Absorption (Trigleride(Trigleride Synthesis)Synthesis)
  • 4. Hypothesis III: Fasting and postprandial hyperlipidemia in insulin resistant states may be attributable in part to intestinal oversecretion of apoB-48 containing lipoproteins Experimental Approach: • Dietary induction of an insulin resistant state in the hamster by high fructose feeding • Isolation of adult viable villi from Syrian hamster small intestine. • -In Vivo Studies to assess production rate of intestinal (apoB48- containing) lipoproteins • -Ex Vivo Studies to assess intestinal apoB48 lipoprotein synthesis and secretion, mechanisms of chylomicron assembly, role of de novo lipogenesis in intestinal lipoprotein secretion in the fasting and postprandial states

Editor's Notes

  1. Key point: The process of cholesterol absorption is complex and currently only partly understood. Cholesterol absorption is a complex, multistep process. Methods of affecting these processes include reducing dietary cholesterol by decreasing intake. Bile acid sequestrants such as cholestyramine and colestipol bind to bile acids, blocking their normal resorption. This increases bile acid excretion resulting in a net cholesterol loss.4,10 The packaging of cholesterol in micelles can be reduced through the use of plant stanol esters, such as sitostanol. These esters are structurally similar to cholesterol and competitively compete with cholesterol for incorporation into micelles.2,5,11,12 Since cholesterol must be packaged in micelles in order to cross the basement membrane of enterocytes, this effectively decreases cholesterol uptake and increases cholesterol secretion. ABCG5 and ABCG8 are proteins involved in sterol excretion.13 ABCA1 is up-regulated by cellular cholesterol and functions to transport cholesterol out of the cell.7-9